Neoantigen Targeted Therapies Market is estimated to be worth USD 3 Billion in 2030
Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to...
Новости пользователей сайта